Anecdotal reports from diabetes care leaders at affiliated facilities and preliminary analysis of insulin administration data suggest that a substantial proportion of the glucose management in COVID‐19 patients is being done via subcutaneous insulin and that there are fewer orders for point of care monitoring of glucose values. Here, INS is linked to diabetes mellitus.